Sustainability | December 22, 2025
Sai Life Sciences unveils 2024–25 sustainability report
The company also reported significant progress toward its internally defined Sustainable Development Goals
The company also reported significant progress toward its internally defined Sustainable Development Goals
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
False positive rates?ranged from 0% to 41%, meaning some labs incorrectly identified bacteria that weren’t present in the sample
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Extended lab space for product development, customer demos, and training
25 women students to receive internship, training, and mentorship in Life Sciences segment
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
Subscribe To Our Newsletter & Stay Updated
